A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.

Shuji Matsuoka; Hiromichi Tsurui; Masaaki Abe; Kazuo Terashima; Kazuhiro Nakamura; Yoshitomo Hamano; Mareki Ohtsuji; Nakayuki Honma; Isao Serizawa; Yasuyuki Ishii

doi:10.1084/jem.20021301

A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.

Identifier:nobleid.org/w1/20260515/D301F092

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D301F092.svg?ark=w1%2F20260515%2FD301F092)](https://nobleid.org/work/w1/20260515/D301F092)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.

Identifier:nobleid.org/w1/20260515/D301F092

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D301F092.svg?ark=w1%2F20260515%2FD301F092)](https://nobleid.org/work/w1/20260515/D301F092)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work